Panteghini M
1 Laboratorio Analisi Chimico-Cliniche, Spedali Civili, Brescia, Italy.
Clin Chem Lab Med. 1998 Nov;36(11):887-93. doi: 10.1515/CCLM.1998.155.
The field of biochemical markers of cardiac damage is in a dynamic state, with new applications continually appearing and new assays and markers being developed. These significant and sudden advancements in the development of new biochemical assays have led however to several analytical and interpretative problems. In this situation, it is essential that a uniform and rigorous outlook be maintained to ensure optimal test utilization. For these reasons, the IFCC Scientific Division recently agreed to establish a Committee on "Standardization of Markers of Cardiac Damage" (C-SMCD), inviting members from the established American and European groups to become members of this Committee. In this presentation, the premises, the issues, and the proposed plan of action of C-SMCD are presented and discussed.
心脏损伤生化标志物领域处于动态发展中，新的应用不断涌现，新的检测方法和标志物也在不断研发。然而，新生化检测方法的这些重大且迅速的进展引发了若干分析和解释方面的问题。在这种情况下，保持统一且严谨的观点以确保检测的最佳利用至关重要。基于这些原因，国际临床化学和检验医学联合会（IFCC）科学部最近同意成立一个“心脏损伤标志物标准化委员会”（C-SMCD），邀请美国和欧洲现有团体的成员加入该委员会。在本报告中，将介绍并讨论C-SMCD的前提、问题及拟议的行动计划。
